The following satellite symposia and workshops are part of unaccredited sponsored activities. They are not part of the ISPAD 2025 accredited educational program planned by the Scientific Committee and do not qualify for Maintenance of Certification Credits.
|
|
Date: Wednesday, November 05 Time: 14:00-15:15 Session Hall 2 (516 CDE) Symposium |
Redrawing the T1D Map: How Early Detection Is Transforming Care for Children
| 14:00 –14:05 | Welcome | Stephen Gitelman |
| 14:05 –14:25 | Screening Is Driving the Transformation in T1D | Loredana Marcovecchio |
| 14:25–14:45 | Talking Transformation with Young People and Their Families | Holly O’Donnell |
| 14:45–15:05 | The Clinical Significance of Beta-cell Preservation in Early-stage T1D | Jacques Beltrand |
| 15:05–15:25 | Charting the Course: New Horizons in T1D Management | Stephen Gitelman |
| 15:25–15:30 | Close | Stephen Gitelman |
|
|
Date: Wednesday, November 05 Time: 14:00-15:15 Workshop room Practical workshop |
Omnipod 5 in Action: Conquering Challenging Cases to Achieve Real-World Success
 |
Date: Thursday, November 06 Time: 08:00-09:00 Session Hall 3 (518 ABC) Symposium |
A New Era in T1D Management – Practical insights for the use of teplizumab in stage 2 T1D patients
| Topic: |
| The Autoimmune paradigm in T1D |
| Teplizumab: MOA & clinical insights |
| Practicalities of teplizumab infusion |
| Panel on real world experience |
| Q&A |
 |
Date: Thursday, November 06 Time: 08:00-09:00 Session Hall 2 (516 CDE) Symposium |
Every minute matters: championing normoglycemia in children with type 1 diabetes
Chair: Jennifer McVean, MD
| Real-World Pediatric Insights | Explore pediatric outcomes with the MiniMed™ 780G system across real-world settings—demonstrating how automated insulin delivery is making a measurable difference in children’s lives. | Jennifer McVean, MD |
| Why Time in Tight Range Matters | Discover the growing body of evidence supporting tighter glycemic metrics in pediatric care. Learn how registries help track progress—and why automation is essential to achieving and sustaining time in tight range. | Thomas Danne, MD, PhD |
| We Need to Do More: Implementing AID ASAP | From early intervention to global implementation, see how real-world outcomes from across the globe reinforce the value of automation—starting at diagnosis. Discuss strategies to operationalize early adoption in clinical practice. | David Maahs, MD, PhD |
| Using the MiniMed™ 780G system to improve Time in Tight Range: Lessons from Latin America | Hear how clinics across Latin America, including Brazil, are succeeding with the MiniMed™ 780G system. Review regional data, understand the power of recommended settings, and uncover how flexibility in bolusing supports real-world success. | Luis Eduardo Calliari, MD |
|
Date: Thursday, November 06 Time: 11:00-11:30 Exhibition Theatre in the exhibition
|
Clinical Implementation of Paediatric T1D Screening: the T1ME is NOW
 |
Date: Thursday, November 06 Time: 14:00-15:15 Session Hall 3 (518 ABC) Symposium |
The Earlier the Better – Reducing Acute Events with early initiation of CGM and AID.
Summary: Discover how early adoption of Dexcom CGM Systems and AID technology can transform pediatric type 1 diabetes (T1D) care. This session presents compelling clinical insights from recent international registry data and clinical studies, highlighting the benefits of early CGM initiation. Attendees will gain practical, step-by-step strategies for integrating Dexcom CGM into early education workflows, supported by caregiver tools and onboarding resources. Evidence from pivotal studies and meta-analyses will showcase how AID systems improve time-in-range and reduce acute events. The session also explores timing considerations for CGM initiation and offers implementation guidance tailored for clinical practice. Designed for healthcare professionals, this program delivers a clear roadmap for elevating care standards and improving care early on in diagnosis.
Speakers: Dr. Anita Swamy and Dr. Shazhan Amed
|
Date: Thursday, November 06 Time: 14:00-15:15 Workshop room Practical workshop |
Taking the Plunge: T1D Early Detection Implementation, Best Practices and Insights, a Global Perspective
 |
Date: Thursday, November 06 Time: 18:00-19:30 Meeting Room 511 Afternoon Symposium |
An Evening with Breakthrough T1D: Personal Journeys and Emerging Therapies in Type 1 Diabetes
Chair: Brynn Marks
Faculty: Kimber Simmons, Peter Senior
Type 1 diabetes (T1D) is a chronic, life-threatening autoimmune disease that impacts nearly 9.5 million Americans of all ages. While it commonly presents in childhood and adolescence, many cases go undetected due to subtle symptoms or a lack of noticeable signs, or diagnosis may be delayed until a serious complication arises.With groundbreaking treatment strategies available and more on the horizon, it is vital for diabetes care and education specialists to grasp the complexities of T1D and to enhance their expertise in screening, staging, and management for both those living with T1D and those at risk. This dynamic symposium offers an engaging blend of interactive and educational components designed to improve recognition and staging of T1D and understanding of new and emerging management strategies.
Patient Journeys by Medscape is an exciting and innovative live format that combines the authenticity and emotion of real patients, the networking and information sharing of a social gathering, the self-guided learning of a poster walk, and the impact of a thought leader-led debrief.
| 17:45 – 18:00 | Registration and Journey Entry |
|
| 18:00 – 18:05 | Welcome and Introduction | |
| 18:05 – 19:30 | Patient Journey Videos Poster Walk and Interaction With Faculty |
|
| 18:35 – 18:55 | Faculty Debrief and Q&A Session 1 | |
| 19:10 – 19:30 | Faculty Debrief and Q&A Session 2 |
 |
Date: Friday, November 07 Time: 08:00-09:00 Session Hall 3 (518 ABC) Symposium |
Every Day, Every Stage: Using Control-IQ Technology to Meet the Unique Needs of Pediatric Patients
Speakers: Gregory Forlenza, MD and Laurel H. Messer, PhD, RN, MPH, CDCES
Description: No two days are the same when you’re treating or living with diabetes. Dr. Gregory Forlenza, pediatric endocrinologist from the Barbara Davis Center in Denver, Colorado, will share strategies used in his clinical practice, and how the Tandem Source platform can be leveraged for simple data interpretation. A 1-page clinical tool and easy quick settings slider will help you meet the needs of children and youths in your practice by providing simple strategies for time in range optimization.
 |
Date: Friday, November 07 Time: 08:00-09:00 Workshop room Practical workshop |
From Research to Real Life: Optimising mylife Loop, powered by mylife CamAPS FX, in Paediatric Type 1 Diabetes
| Behind the numbers: a mother’s perspective on life with mylife Loop | |
| Advancing Paediatric Diabetes Care with mylife CamAPS FX: Lessons from Clinical Research | Martin Tauschmann |
| From Initiation to Personalisation: Practical Tips for Safe and Effective Use | Julia Ware |
Description: This symposium showcases how clinical evidence can be translated into real-world paediatric diabetes care. A parent testimony brings to life the everyday impact of the mylife Loop, while Dr. Martin Tauschmann highlights key clinical findings in children with type 1 diabetes. Dr. Julia Ware provides practical guidance for safe initiation and effective individualisation. Together, these perspectives equip clinicians with valuable insights to optimise outcomes with mylife Loop powered by mylife CamAPS FX in paediatric practice.
 |
Date: Friday, November 07 Time: 14:00-15:15 Session Hall 1 (517 A) Symposium |
Transforming Pediatric Diabetes Management with AID, the Latest CGM Technology, and Ketone Monitoring
| 14:00 –14:20 | Welcome
Current challenges in managing children with T1D |
Dr. Farid Mahmud |
| 14:20 –14:40 | Importance of AID choice for children and caregiver |
Dr. Fiona Campbell |
| 14:40–15:00 | Protecting the young from dual threat; future of ketone monitoring | Dr. Jen Sherr |
